NUCLEOLIN and cancer: Looking ahead, it is anticipated that more clinical studies will confirm the potential of NCL as a therapeutic target for lung adenocarcinoma, with the hope of developing treatment strategies based on key targets to enhance the survival rates of patients with this type of cancer.